NASA astronauts Butch Wilmore and Suni Williams are steadily recovering after spending nine unexpected months aboard the International Space Station (ISS) due to issues with Boeing’s Starliner capsule. Initially intended for an eight-day test flight, the mission extended when Starliner experienced propulsion problems that forced NASA to return the capsule uncrewed in 2023.
The astronauts returned to Earth in March 2025 and have since undergone intensive physical therapy to readjust to gravity. Wilmore, 62, noted the difficulties of re-adapting to Earth's conditions, saying, “Gravity stinks for a period.” Williams, 59, echoed the challenges, highlighting muscle fatigue and delayed energy recovery. Both astronauts spent about two hours daily with NASA’s reconditioning specialists during a standard 45-day rehab period.
Despite lingering issues, such as neck pain for Wilmore and fatigue for Williams, both are now supporting Boeing and NASA operations, helping evaluate the Starliner program and contributing to ISS-related research. Wilmore noted that some of his preexisting physical pain vanished in microgravity but returned immediately upon splashdown.
Boeing has already incurred over $2 billion in costs developing Starliner and is awaiting a key decision from NASA: whether to mandate another uncrewed flight before resuming crewed missions. Williams supports the idea, citing the cautious approach taken by SpaceX and Russia in launching uncrewed missions before sending astronauts.
NASA expects to complete tests of Starliner over the summer, which will determine if it’s ready to fly humans again. Williams and Wilmore continue to be key figures in that assessment as Boeing aims to regain trust in its human spaceflight program.
The Starliner setback adds to Boeing’s ongoing challenges, contrasting with the consistent performance of rival capsules developed by SpaceX. NASA’s upcoming decision will be pivotal for Boeing’s future in space exploration.


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Neuralink Expands Brain Implant Trials with 12 Global Patients
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Instagram Outage Disrupts Thousands of U.S. Users
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 



